These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 30761522

  • 1. Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth.
    Qiu J, Li Q, Bell KA, Yao X, Du Y, Zhang E, Yu JJ, Yu Y, Shi Z, Jiang J.
    Br J Pharmacol; 2019 Jun; 176(11):1680-1699. PubMed ID: 30761522
    [Abstract] [Full Text] [Related]

  • 2. Complementary roles of EP2 and EP4 receptors in malignant glioma.
    Qiu J, Li Q, Li J, Zhou F, Sang P, Xia Z, Wang W, Wang L, Yu Y, Jiang J.
    Br J Pharmacol; 2023 Oct; 180(20):2623-2640. PubMed ID: 37232020
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV, Xu G, Chakrabarti S, Lala PK, Chakraborty C.
    Exp Cell Res; 2003 Oct 01; 289(2):265-74. PubMed ID: 14499627
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
    Hsu HH, Lin YM, Shen CY, Shibu MA, Li SY, Chang SH, Lin CC, Chen RJ, Viswanadha VP, Shih HN, Huang CY.
    Int J Mol Sci; 2017 May 25; 18(6):. PubMed ID: 28587064
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
    Francica BJ, Holtz A, Lopez J, Freund D, Chen A, Wang D, Powell D, Kipper F, Panigrahy D, Dubois RN, Whiting CC, Prasit P, Dubensky TW.
    Cancer Res Commun; 2023 Aug 25; 3(8):1486-1500. PubMed ID: 37559947
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ, Gilbert M, Pullen N, Skerratt S, Farrington J, Seward EP, Peachell PT.
    Clin Exp Allergy; 2013 Jul 25; 43(7):741-51. PubMed ID: 23786281
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of lysyl oxidase by prostaglandin E2 via EP2/EP4 receptors in human amnion fibroblasts: Implications for parturition.
    Liu C, Zhu P, Wang W, Li W, Shu Q, Chen ZJ, Myatt L, Sun K.
    Mol Cell Endocrinol; 2016 Mar 15; 424():118-27. PubMed ID: 26826430
    [Abstract] [Full Text] [Related]

  • 15. PGE2 potentiates tonicity-induced COX-2 expression in renal medullary cells in a positive feedback loop involving EP2-cAMP-PKA signaling.
    Steinert D, Küper C, Bartels H, Beck FX, Neuhofer W.
    Am J Physiol Cell Physiol; 2009 Jan 15; 296(1):C75-87. PubMed ID: 19005164
    [Abstract] [Full Text] [Related]

  • 16. Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation.
    Jiang J, Dingledine R.
    J Pharmacol Exp Ther; 2013 Feb 15; 344(2):360-7. PubMed ID: 23192657
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.